Your Article Summary
Data from a head-to-head crossover study evaluating FOSRENOL
Shire, 10/08/09
Shire plc, the global specialty biopharmaceutical company, announces the publication in Clinical Nephrology of findings from a head–to–head clinical study comparing the efficacy of two non–calcium based phosphate binders, FOSRENOL and sevelamer hydrochloride in chronic kidney disease patients on haemodialysis.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor


See Latest Articles


